ASAHL activators encompass a class of compounds distinguished by their interaction with the enzyme N-acylethanolamine acid amidase (ASAHL), leading to an increase in its enzymatic activity. ASAHL is central to the catabolism of fatty acid amides, a category of bioactive lipids implicated in various cellular signaling processes. The defining characteristic of ASAHL activators is their capacity to amplify ASAHL's catalytic efficiency, resulting in an elevated rate of substrate turnover. This heightened enzymatic activity propels the rapid degradation of fatty acid amides, thereby modulating their concentrations and biological actions within the cell.
The mechanisms through which ASAHL activators exert their effect are anchored in their direct or allosteric interaction with the enzyme. Activators engaging directly with ASAHL typically bind in proximity to its active site. This binding stabilizes the transition state or augments the enzyme's affinity for its substrates, thereby enhancing its catalytic function. Allosteric activators operate through an alternative route, binding to sites on the enzyme distinct from the active site. This interaction triggers conformational changes that reverberate to the active site, culminating in a surge in ASAHL's catalytic activity. Such precise modulation of enzyme function by ASAHL activators can lead to significant alterations in the metabolism of fatty acid amides, influencing the myriad signaling pathways they regulate.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palmitoylethanolamide | 544-31-0 | sc-202754 sc-202754A sc-202754B sc-202754C sc-202754D | 10 mg 50 mg 500 mg 1 g 10 g | $80.00 $243.00 $2091.00 $3339.00 $16657.00 | ||
Enhances endocannabinoid signaling, potentially increasing ASAHL activity to maintain homeostasis in fatty acid amides | ||||||
Oleylethanolamide | 111-58-0 | sc-201400 sc-201400A | 10 mg 50 mg | $90.00 $194.00 | 1 | |
As a lipid mediator, it could indirectly upregulate ASAHL activity to balance levels of fatty acid amides. | ||||||
α-Linolenic Acid | 463-40-1 | sc-205545 sc-205545A | 50 mg 250 mg | $38.00 $115.00 | 2 | |
Its metabolism can involve fatty acid amides, possibly influencing ASAHL activity indirectly. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $104.00 $431.00 | ||
May impact fatty acid amide levels, indirectly modulating ASAHL activity. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
Could alter ASAHL activity indirectly through its role in fatty acid amide metabolism. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
Its metabolites interact with fatty acid amide pathways, potentially affecting ASAHL activity. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Engages endocannabinoid system, possibly altering ASAHL activity to regulate fatty acid amide levels. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates lipid signaling pathways, which might indirectly impact ASAHL activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Influences lipid metabolism and signaling, potentially modulating ASAHL activity indirectly. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Antioxidant properties may affect fatty acid amide metabolism, possibly impacting ASAHL activity. | ||||||